News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Dana-Farber Cancer Institute
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Study Finds Tarceva Benefits Older Lung Cancer Patients
October 19, 2005
·
1 min read
Scientists Shut Off Leukemia Gene In Mice
October 19, 2005
·
1 min read
Cloning Experiment Shows Cancer Reversible
October 19, 2005
·
1 min read
Malignant Cancer Cells Generate Mice Through Cloning
October 19, 2005
·
1 min read
Master Blood Cell Gene Identified
October 19, 2005
·
1 min read
Optimizing Protein’s “Death Domain” Halts Leukemia In Laboratory Study
October 19, 2005
·
1 min read
Drug Development
Monkey Protein Fights HIV From Inside Cells
October 19, 2005
·
1 min read
Biotech Beach
Scientists Find Gene That Blocks HIV; Monkey’s Protein Prevents HIV
October 19, 2005
·
1 min read
Genetown
Novel Combination Overcomes Drug-Resistant Myeloma Cells
October 19, 2005
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer
January 23, 2026
·
4 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
December 16, 2025
·
19 min read
Press Releases
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
December 16, 2025
·
19 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Updated Phase 3 Tabelecleucel Data at American Society of Hematology Meeting in Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
December 8, 2025
·
7 min read
Press Releases
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
December 2, 2025
·
4 min read
Press Releases
Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
November 20, 2025
·
4 min read
Press Releases
Red Queen Therapeutics Announces Expanded Licensing Agreement, Progress in Its Pan-Influenza Program
December 3, 2024
·
4 min read
invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology
October 15, 2024
·
4 min read
Pharm Country
Grant Awarded to Identify New Druggable Targets in Gastroesophageal Cancer
January 30, 2024
·
2 min read
Genetown
invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma
November 9, 2023
·
5 min read
